Samia H. Lopa, PhD

Research Assistant Professor
Ph.D. (2014) University of Pittsburgh

Contact Information

University of Rochester
Department of Biostatistics and Computational Biology
265 Crittenden Blvd, CU 420630
Rochester, New York 14642-0630

Office: Saunders Research Building 4161
Phone: (585) 274-1622
Fax: (585) 273-1031
E-mail: samia_lopa@urmc.rochester.edu

Research Interests

My research interest is in the design and analysis of clinical studies, analysis of longitudinal and clustered data, and survival analysis.

I have collaborative research experience in breast cancer, colorectal and other urological and endometrial cancers, and more recently, in reproductive health and pregnancy outcomes. 

Selected Publications

• Brieño-Enríquez MA, Faykoo-Martinez M, Goben M, Grenier JK, McGrath A, Prado AM, Sinopoli J, Wagner K, Walsh PT, Lopa SH, Laird DJ. Postnatal oogenesis leads to an exceptionally large ovarian reserve in naked mole-rats. Nature Communications. 2023 Feb 21;14(1):670.
• Lei M, Adambekov S, Edwards RP, Wang R, Yuan JM, Kalix E, Lopa S, Linkov F. Endometrial cancer risk factors in Singapore Chinese: A prospective cohort study. Annals of Epidemiology. 2022 Apr 21.
• Ackenbom MF, Zyczynski HM, Butters MA, Lopa S, Orris SR, Davis EM. Postoperative delirium in older patients after undergoing pelvic organ prolapse surgery. International Urogynecology Journal. 2022 Apr 11:1-9.
• Wang T, Krishnamurti T, Bernard M, Lopa S, Quinn B, Simhan H. Perceptions and knowledge of COVID-19 vaccine safety and efficacy among vaccinated and non-vaccinated obstetric healthcare workers. Behavioral Medicine. 2021 Dec 29:1-3.
• Qi M, Lopa S, Adambekov S, Harris JA, Mansuria S, Edwards RP, Linkov F. Same-day discharge after minimal invasive hysterectomy: Applications for improved value of care. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 Apr 1;259:140-5.
• Hugar LA, Yabes JG, Filippou P, Wulff-Burchfield EM, Lopa SH, Gore J, Davies BJ, Jacobs BL. High-intensity end-of-life care among Medicare beneficiaries with bladder cancer. Urologic Oncology: Seminars and Original Investigations 2021 Oct 1 (Vol. 39, No. 10, pp. 731-e17). Elsevier.
• Adambekov S, Lopa S, Edwards RP, Lemon L, Wang S, Taylor SE, Orr B, Linkov F. Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data. Cancer Medicine. 2020 Oct 1.
• Sutton EF, Rogan SC, Lopa S, Sharbaugh D, Muldoon MF, Catov JM. Early pregnancy blood pressure elevations and risk for maternal and neonatal morbidity. Obstetrics & Gynecology. 2020 Jul 1;136(1):129-39.
• Macleod LC, Fam MM, Yabes JG, Hale NE, Turner II RM, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL. Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. 2020 Jun 1;18(3):201-9.
• Allegra, Carmen J; Yothers, Greg; O'Connell, Michael J; Sharif, Saima; Petrelli, Nicholas J; Lopa, SH; Wolmark, Norman; (2013). Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial Journal of Clinical Oncology Vol.31(3) pp 359-364.

Last updated: March 2, 2023